1:17-cv-01653 - Delcor Asset Corp et al. v. Stiefel West Coast LLC et al.

Detail

Case Number

1:17-cv-01653

Current Status

closed

Cause of Action

Infringement

Related Case(s)

1:17-cv-00970

Court

Delaware District Court

Plaintiff(s)

Delcor Asset Corp

Mylan Pharmaceuticals Inc

Defendant(s)

Stiefel West Coast LLC

Glenmark Pharmaceuticals SA

Mylan Pharmaceuticals Inc

Judge

Richard G. Andrews

Filing Date

2017-11-15

Termination Date

2019-03-05

Not a member? Sign up for free!
Dockets
Text
Feb 1 2018 3:22AM
UPDATED CIVIL DOCKET
Pro Hac Vice Attorney Kathleen B. Barry,Claire A. Fundakowski,Maureen L. Rurka for Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) (Entered: 01/22/2018)
COMPLAINT FOR PATENT INFRINGEMENT filed against Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited, Stiefel West Coast, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2266881.) - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(nmfn) (Entered: 11/15/2017)
Partial Motion to Dismiss Third Counterclaim - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Attachments: # 1 Proposed Order)(Palapura, Bindu) Modified on 2/20/2018 (nms). (Entered: 02/16/2018)
ANSWERING BRIEF in Opposition re 28 Partial Motion to Dismiss Third Counterclaim filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.Reply Brief due date per Local Rules is 3/19/2018. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Gattuso, Dominick) (Entered: 03/12/2018)
NOTICE of Third Party Subpoena of Joseph R. Snyder to Testify at a Deposition by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 05/08/2018)
NOTICE of Third Party Subpoena of Joseph R. Snyder for the Production of Documents by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 05/08/2018)
NOTICE of Third Party Subpoena for the Production of Documents (Perrigo Company) by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 05/08/2018)
NOTICE of Third Party Subpoena for the Production of Documents, by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) Modified on 5/29/2018 (nms). (Entered: 05/24/2018)
NOTICE of Third Party Subpoena of Joshua Goldberg to Testify at a Deposition by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 05/30/2018)
NOTICE of Third Party Subpoena of Joshua Goldberg for the Production of Documents by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 05/30/2018)
NOTICE of Third Party Subpoena of Joseph R. Snyder to Testify at a Deposition, by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited, Stiefel West Coast, LLC.(Attachments: # 1 Exhibit 1)(Gattuso, Dominick) Modified on 6/5/2018 (nms). (Entered: 06/05/2018)
Joint Claim Construction Chart, by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibits B-M)(Palapura, Bindu) Modified on 6/6/2018 (nms). (Entered: 06/05/2018)
Letter to The Honorable Richard G. Andrews from Dominick T. Gattuso regarding Rescheduling Markman Hearing. (Attachments: # 1 Stipulation and Proposed Order)(Gattuso, Dominick) (Entered: 08/01/2018)
[SEALED] Joint Appendix re 84 Joint Claim Construction Brief, by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibits 1-24)(Moore, David) Modified on 9/13/2018 (nms). (Entered: 09/12/2018)
REDACTED VERSION of 85 Appendix by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1-24)(Moore, David) (Entered: 09/19/2018)
[SEALED] Joint Status Report, by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) Modified on 12/10/2018 (nms). (Entered: 12/07/2018)
REDACTED VERSION of 99 Status Report by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 12/13/2018)
NOTICE of Third Party Subpoena of Taro Pharmaceutical Industries, Ltd. for the Production of Documents by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited (Attachments: # 1 Exhibit 1)(Gattuso, Dominick) (Entered: 01/31/2019)
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/2/2017. Date of Expiration of 237 Patent: 1/23/2024. Date of Expiration of 747 Patent: 8/9/2026. Thirty Month Stay Deadline: 4/2/2020. (nmfn) (Entered: 11/15/2017)
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmfn) (Entered: 11/15/2017)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,141,237; 7,374,747. (nmfn) (Entered: 11/15/2017)
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc., Corporate Parent Mylan N.V. for Delcor Asset Corporation filed by Delcor Asset Corporation. (nmfn) (Entered: 11/15/2017)
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc., Corporate Parent Mylan N.V. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc. (nmfn) (Entered: 11/15/2017)
SUMMONS Returned Executed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. Stiefel West Coast, LLC served on 11/15/2017, answer due 12/6/2017. (Moore, David) (Entered: 11/16/2017)
SUMMONS Returned Executed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. Glenmark Pharmaceuticals Inc., USA served on 11/16/2017, answer due 12/7/2017. (Moore, David) (Entered: 11/16/2017)
MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Lance Soderstrom, Stephanie M. Roberts, Joseph M. Janusz, and Derek S. Neilson of Alston & Bird LLP - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Main Document 9 replaced on 11/27/2017) (nms). (Entered: 11/16/2017)
STIPULATION TO EXTEND TIME for Defendants to answer, move, or otherwise respond to the Complaint to January 15, 2018 - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 11/28/2017)
MOTION for Pro Hac Vice Appearance of Attorney Maureen L. Rurka, Kathleen B. Barry and Claire A. Fundakowski - filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 01/12/2018)
ANSWER to 1 Complaint, Affirmative Defenses, CROSSCLAIMS against Delcor Asset Corporation, Mylan Pharmaceuticals Inc., Stiefel West Coast, LLC, and COUNTERCLAIMS against Delcor Asset Corporation, Mylan Pharmaceuticals Inc., by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) Modified on 1/16/2018 (nms). (Entered: 01/12/2018)
ANSWER to 1 Complaint, Affirmative Defenses, CROSSCLAIMS against Delcor Asset Corporation, Mylan Pharmaceuticals Inc., Stiefel West Coast, LLC, and COUNTERCLAIMS against Delcor Asset Corporation, Mylan Pharmaceuticals Inc., by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) Modified on 1/16/2018 (nms). (Entered: 01/12/2018)
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Glenmark Pharmaceuticals Limited for Glenmark Pharmaceuticals Inc., USA filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 01/12/2018)
ANSWER to 1 Complaint, by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 01/16/2018)
ANSWER to 1 Complaint, by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 01/16/2018)
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Stiefel Labs, LLC, Other Affiliate GlaxoSmithKline plc for Stiefel West Coast, LLC filed by Stiefel West Coast, LLC. (Farnan, Brian) (Entered: 01/16/2018)
STIPULATION For Extension of Time to respond to Counterclaims and Crossclaims to February 16, 2018 - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 1/25/2018 (nms). (Entered: 01/25/2018)
STIPULATION TO EXTEND TIME for Defendant Stiefel West Coast, LLC to Respond to Defendants Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USAs Crossclaims to 2/16/2018 - filed by Stiefel West Coast, LLC. (Farnan, Michael) (Entered: 01/31/2018)
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 2/13/2018, at 3:00 PM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 2/1/2018. (nms) (Entered: 02/02/2018)
MOTION for Pro Hac Vice Appearance of Attorney Robert W. Ashbrook, Jr. - filed by Stiefel West Coast, LLC. (Farnan, Brian) (Entered: 02/02/2018)
PROPOSED Scheduling Order, by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 2/12/2018 (nms). (Entered: 02/09/2018)
Letter to The Honorable Richard G. Andrews, from Bindu A. Palapura, Esq., enclosing proposed Scheduling Order. (Palapura, Bindu) Modified on 2/12/2018 (nms). (Entered: 02/09/2018)
NOTICE OF SERVICE of Defendants Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USAs Core Technical Documents (Bates range GEVOC_0000001 - GEVOC_0005202) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/13/2018)
MOTION for Pro Hac Vice Appearance of Attorney Jitendra Malik, Ph.D. and Alissa M. Pacchioli of Alston & Bird LLP - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 02/15/2018)
NOTICE OF SERVICE of Glenmarks First Set of Requests for Production of Documents (Nos. 1-4) to Plaintiffs filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/16/2018)
NOTICE OF SERVICE of Glenmarks First Set of Requests for Production of Documents (Nos. 1-4) to Stiefel filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/16/2018)
ANSWER to 12 Answer to Complaint, and Crossclaims, by Stiefel West Coast, LLC.(Farnan, Michael) Modified on 2/20/2018 (nms). (Entered: 02/16/2018)
Proposed Scheduling Order, by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 2/20/2018 (nms). (Entered: 02/16/2018)
OPENING BRIEF in Support re 28 Partial Motion to Dismiss Third Counterclaim, filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 3/2/2018. (Palapura, Bindu) Modified on 2/20/2018 (nms). (Entered: 02/16/2018)
ANSWER to 12 Answer to Complaint, and Crossclaims, by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) Modified on 2/20/2018 (nms). (Entered: 02/16/2018)
Official Transcript of Scheduling Conference held on 02-13-18 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/12/2018. Redacted Transcript Deadline set for 3/20/2018. Release of Transcript Restriction set for 5/18/2018. (lad) (Entered: 02/17/2018)
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/31/2018. Amended Pleadings due by 8/31/2018. Discovery due by 3/8/2019. Joint Claim Construction Brief due by 8/31/2018. A Pretrial Conference is set for 11/15/2019, at 9:00 AM in Courtroom 6A. A 3 day Jury Trial is set to start 12/2/2019, at 08:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 2/20/2018. (nms) (Entered: 02/20/2018)
ORDER Setting Teleconference: Plaintiffs counsel to initiate the call. A Telephone Conference is set for 3/20/2018 at 10:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 2/21/18. (cak) (Entered: 02/21/2018)
STIPULATION TO EXTEND TIME to Respond to Plaintiffs Partial Motion to Dismiss to March 12, 2018 - filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 02/28/2018)
DEMAND for Trial by Jury by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 03/02/2018)
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 9, 2018 - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/02/2018)
NOTICE OF SERVICE of Glenmarks Initial Disclosures filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 03/06/2018)
NOTICE OF SERVICE of Stiefel West Coast, LLCs Initial Disclosures filed by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 03/06/2018)
NOTICE OF SERVICE of Plaintiffs Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/07/2018)
NOTICE OF SERVICE of Plaintiffs First Set of Interrogatories to the Glenmark Defendants (Nos. 1-11), and Plaintiffs First Set of Requests for the Production of Documents and Things to the Glenmark Defendants (Nos. 1-78) filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 03/07/2018)
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 14, 2018 - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/08/2018)
STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to March 19, 2018 - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 03/14/2018)
REPLY BRIEF re 28 Partial Motion to Dismiss Third Counterclaim filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 03/19/2018)
NOTICE OF SERVICE of Stiefel West Coast, LLCs Responses and Objections to Glenmarks Requests for Production Nos. 1-4 filed by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 03/19/2018)
NOTICE OF SERVICE of Plaintiffs Objections and Responses to Glenmarks First Set of Requests for Production of Documents (Nos. 1-4) filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 03/20/2018)
NOTICE OF SERVICE of Plaintiffs Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 03/22/2018)
NOTICE OF SERVICE of Glenmarks Default Standard for Discovery Paragraph 3 Initial Disclosures filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 03/22/2018)
NOTICE OF SERVICE of Stiefel West Coast, LLCs Default Standard 3 Initial Disclosures filed by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 03/22/2018)
NOTICE OF SERVICE of Plaintiffs Paragraph 4(c) Disclosures Pursuant to the Delaware Default Standard for Discovery (Outside Counsel Eyes Only) filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 03/27/2018)
NOTICE OF SERVICE of 1) Glenmarks First Set of Interrogatories (Nos. 1-9) to Plaintiffs; and 2) Glenmarks Second Set of Requests for Production of Documents (Nos. 5-95) to Plaintiffs filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 04/02/2018)
NOTICE OF SERVICE of 1) Glenmarks First Set of Interrogatories (Nos. 1-8) to Stiefel; and 2) Glenmarks Second Set of Requests for Production of Documents (Nos. 5-95) to Stiefel filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 04/02/2018)
NOTICE OF SERVICE of 1) Glenmarks Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-11); and 2) Glenmarks Responses and Objections to Plaintiffs First Set of Requests for Production of Documents (Nos. 1-78) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 04/05/2018)
Proposed STIPULATED Protective Order, by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) Modified on 4/10/2018 (nms). (Entered: 04/10/2018)
SO ORDERED Granting 55 Stipulated Protective Order. Signed by Judge Richard G. Andrews on 4/10/2018. (nms) (Entered: 04/11/2018)
NOTICE OF SERVICE of Glenmarks Initial Invalidity Contentions Regarding U.S. Patent Nos. 7,141,237 and 7,374,747 filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 04/25/2018)
NOTICE of Change of Firm Affiliation by Delcor Asset Corporation, Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 05/01/2018)
MOTION for Pro Hac Vice Appearance of Attorney Lauren C. Tortorella - filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 05/04/2018)
SUBPOENA Returned Executed as to Perrigo Company on May 9, 2018 (Gattuso, Dominick) (Entered: 05/10/2018)
NOTICE OF SERVICE of Glenmarks Preliminary List of Claim Terms That Require Construction filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 05/11/2018)
NOTICE of Change of Firm Affiliation for Alissa M. Pacchioli by Delcor Asset Corporation, Mylan Pharmaceuticals Inc. (Palapura, Bindu) (Entered: 05/14/2018)
NOTICE requesting Clerk to remove Derek S. Neilson of Alston & Bird LLP as co-counsel. Reason for request: no longer working on the case. (Palapura, Bindu) (Entered: 05/14/2018)
NOTICE OF SERVICE of Plaintiffs Identification of Claim Term(s) and Initial Proposed Construction(s) filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 05/14/2018)
NOTICE OF SERVICE of (i) Stiefel West Coast, LLCs Responses and Objections to Glenmarks First Requests for Production and (ii) Stiefel West Coast, LLCs Responses and Objections to Glenmarks First Set of Interrogatories filed by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 05/14/2018)
STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to June 5, 2018 - filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 06/01/2018)
STIPULATION TO EXTEND TIME to serve Opening Claim Construction Brief, and to serve Answering Claim Construction Brief to June 25, 2018 and July 16, 2018 - filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 6/22/2018 (nms). (Entered: 06/21/2018)
NOTICE to Take Deposition of Barrett Rabinow on July 6, 2018 filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 07/02/2018)
NOTICE OF SERVICE of Glenmarks Answering Claim Construction Brief filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 07/16/2018)
NOTICE to Take Deposition of Maureen Donovan on July 24, 2018 filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 07/23/2018)
NOTICE to Take Deposition of Pavel Nagorny on July 26, 2018 filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 07/23/2018)
NOTICE OF SERVICE of Plaintiffs Delcor Asset Corp. and Mylan Pharmaceuticals Inc.s Reply Claim Construction Brief filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 08/20/2018)
NOTICE OF SERVICE of Glenmarks Sur-Reply Claim Construction Brief and Joint Appendix Exhibit 24 filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 09/10/2018)
[SEALED] Joint Claim Construction Brief, filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 9/13/2018 (nms). (Entered: 09/12/2018)
REDACTED VERSION of 84 Joint Claim Construction Brief, by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 9/20/2018 (nms). (Entered: 09/19/2018)
NOTICE OF SERVICE of Glenmarks Second Set of Interrogatories (Nos. 9-15) to Stiefel filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 09/20/2018)
NOTICE OF SERVICE of 1) Glenmarks Second Set of Interrogatories (Nos. 10-16) to Plaintiffs; and 2) Glenmarks Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-11) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 09/20/2018)
MEMORANDUM ORDER: The Partial Motion to Dismiss Glenmarks Third Counterclaim (D.I. 28 ) is GRANTED. Signed by Judge Richard G. Andrews on 9/21/2018. (nms) (Entered: 09/21/2018)
NOTICE OF SERVICE of Stiefel West Coast, LLCs Responses and Objections to Glenmarks Interrogatories 9-15 filed by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 10/22/2018)
NOTICE OF SERVICE of Mylans Responses and Objections to Glenmarks Second Set of interrogatories (Nos. 10-16) to Plaintiffs filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 10/26/2018)
MEMORANDUM ORDER providing claim construction for multiple terms in U.S. Patent Nos. 7,141,237 and 7,374,747. Signed by Judge Richard G. Andrews on 10/31/2018. (nms) (Entered: 10/31/2018)
NOTICE OF SERVICE of Plaintiffs Second Set of Interrogatories to the Glenmark Defendants (No. 12) filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 11/02/2018)
NOTICE OF SERVICE of Glenmarks Third Set of Interrogatories (Nos. 17-19) to Plaintiffs filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 11/07/2018)
Official Transcript of Markman Hearing held on 10/19/2018 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 12/5/2018. Redacted Transcript Deadline set for 12/17/2018. Release of Transcript Restriction set for 2/12/2019. (Triozzi, Heather) (Entered: 11/14/2018)
NOTICE OF SERVICE of Plaintiffs Second Set of Requests for the Production of Documents and Things to Glenmark (No. 79) [CONFIDENTIAL] filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 11/30/2018)
NOTICE OF SERVICE of Glenmarks Responses and Objections to Plaintiffs Second Set of Interrogatories (No. 12) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 12/03/2018)
NOTICE OF SERVICE of Mylans Responses and Objections to Glenmarks Third Set of Interrogatories (Nos. 17-19) to Plaintiffs filed by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/07/2018)
NOTICE OF SERVICE of Glenmarks Responses and Objections to Plaintiffs Second Set of Requests for Production of Documents (No. 79) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 12/28/2018)
NOTICE to Take Deposition of Mark Buggy on January 8, 2019 filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 01/04/2019)
[SEALED] NOTICE to Take Deposition of Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USA on dates agreed upon by the parties filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 01/07/2019)
NOTICE OF SERVICE of Glenmarks Third Set of Requests for Production of Documents (Nos. 96-97) to Plaintiffs filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 01/10/2019)
NOTICE to Take Deposition of Plaintiffs on a mutually agreeable date filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) Modified on 1/11/2019 (nms). (Entered: 01/10/2019)
NOTICE OF SERVICE of Glenmarks Third Set of Requests for Production of Documents (Nos. 96-97) to Stiefel filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 01/10/2019)
NOTICE to Take Deposition of Stiefel on a mutually agreeable date filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) Modified on 1/11/2019 (nms). (Entered: 01/10/2019)
NOTICE requesting Clerk to remove Robert W. Ashbrook, Jr. as co-counsel.. (Farnan, Brian) (Entered: 01/10/2019)
MOTION for Pro Hac Vice Appearance of Attorney Brian M. Goldberg - filed by Stiefel West Coast, LLC. (Farnan, Brian) (Entered: 01/10/2019)
REDACTED VERSION of 104 Notice to Take Deposition of Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USA, by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) Modified on 1/23/2019 (nms). (Entered: 01/18/2019)
NOTICE OF SERVICE of Plaintiffs First Set Of Requests For Admission To Glenmark Pharmaceuticals Limited And Glenmark Pharmaceuticals Inc., USA (Nos. 1-25) [Confidential] filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 01/18/2019)
NOTICE OF SERVICE of Plaintiffs Third Set of Interrogatories to the Glenmark Defendants (No. 13); Plaintiffs First Supplemental Responses and Objections to Glenmarks Second Set of Interrogatories (Nos. 10-16); and Plaintiffs Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 01/25/2019)
NOTICE OF SERVICE of Plaintiffs First Supplemental Objections and Responses to Glenmarks First Set of Interrogatories (Nos. 1-9) [Confidential] filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 01/29/2019)
MOTION for Pro Hac Vice Appearance of Attorney Elizabeth E. Grden - filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) (Entered: 02/01/2019)
NOTICE OF SERVICE of 1) Glenmarks First Set of Request for Admission (Nos. 1-22) to Plaintiffs; and 2) Glenmarks Fourth Set of Interrogatories (Nos. 20-22) to Plaintiffs filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/05/2019)
NOTICE OF SERVICE of Glenmarks Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/05/2019)
NOTICE OF SERVICE of Glenmarks First Set of Requests for Admission (Nos. 1-25) to Stiefel filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/05/2019)
NOTICE of Withdrawal of Lauren C. Tortorella, by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited. (Gattuso, Dominick) Modified on 2/8/2019 (nms). (Entered: 02/08/2019)
NOTICE OF SERVICE of Stiefel West Coast, LLCs Responses and Objections to Glenmarks Third Set of Requests for Production of Documents (Nos. 96-97) filed by Stiefel West Coast, LLC.(Farnan, Brian) (Entered: 02/11/2019)
NOTICE OF SERVICE of Plaintiffs Objections and Responses to Glenmarks Third Set of Requests for Production of Documents (Nos. 96-97) filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 02/11/2019)
NOTICE OF SERVICE of Plaintiffs Responses and Objections to Glenmarks Notice of Rule 30(b)(6) Deposition filed by Delcor Asset Corporation, Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 02/12/2019)
NOTICE OF SERVICE of Glenmarks Objections and Responses to Plaintiffs First Set of Requests for Admission (Nos. 1-25) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/15/2019)
NOTICE OF SERVICE of Glenmarks Supplemental Default Standard for Discovery Paragraph 3 Initial Disclosures filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/21/2019)
NOTICE OF SERVICE of Glenmarks Responses and Objections to Plaintiffs Third Set of Interrogatories (No. 13) filed by Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Limited.(Gattuso, Dominick) (Entered: 02/25/2019)
STIPULATION of Dismissal by Delcor Asset Corporation, Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 03/05/2019)
SO ORDERED Granting 128 Stipulation and Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 3/5/2019. (nms) (Entered: 03/05/2019)
Timeline
filed_date
closed_date
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Patents In Case

Not a member? Sign up for free!